/
Company Overview CareDx is a precision medicine company dedicated to improving outcomes for transplant patients and advancing organ health. We deliver solutions designed to empower clinicians and improve patient outcomes.
The business is unprofitable at the operating level (-8.10% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 13.8%, still solid. Margins contracted 20.3pp, which offsets some of the top-line progress.
ROIC dropped from 11.52% to -6.61%, capital efficiency is deteriorating. Operating margin contracted 20.3pp YoY, cost discipline may be slipping.
Profitability & Returns
Revenue (TTM)
$413M
▲ +13.8% YoY
Net Income (TTM)
-$8M
▼ -140.6% YoY
Op. Margin
-3.93%
▼ -20.3pp YoY
ROIC
-3.76%
▼ -18.1pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
$73M
▲ +10.5% YoY
Net Debt
-$163M
Net Cash Position
Cash & Equiv.
$187M
5Y CAGR: +14.6%
Continue Research